Cite
How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia
MLA
Annamaria Frustaci, et al. “How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia.” Blood, vol. 140, Nov. 2022, pp. 6528–30. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........33a82155a4b1947fd26568e1dc8a6f47&authtype=sso&custid=ns315887.
APA
Annamaria Frustaci, Francesco Piazza, Simone Ferrero, Gianluigi Reda, Rita Rizzi, Lorella Orsucci, Isacco Ferrarini, Marina Deodato, Luca Laurenti, Benedetta Puccini, Claudia Baratè, Marzia Varettoni, Michele Merli, Emanuele Cencini, Antonino Greco, Guido Gini, Angela Ferrari, Chiara Borella, Enrico Lista, … Alessandra Tedeschi. (2022). How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia. Blood, 140, 6528–6530.
Chicago
Annamaria Frustaci, Francesco Piazza, Simone Ferrero, Gianluigi Reda, Rita Rizzi, Lorella Orsucci, Isacco Ferrarini, et al. 2022. “How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia.” Blood 140 (November): 6528–30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........33a82155a4b1947fd26568e1dc8a6f47&authtype=sso&custid=ns315887.